fgf4 gene Search Results


88
Thermo Fisher gene exp fgf4 hs00173564 m1
Molecular characterization and identification of 10% strain applied human ESCs for 2 h via qRT-PCR analysis for temporal expression of (A) pluripotency (NANOG, OCT4, SOX2, and KLF4), (B) trophoctoderm markers (CDX2, EOMES, EpCAM, and <t>FGF4),</t> (C) ecto- and endodermal lineage differentiation (WNT3A, SOX17, GATA6, and PAX6), and (D) cytoskeletal, focal adhesion kinase (Ptk2) and PXN (Paxillin), Integrin alpha 6 (ITGA6) and E-CADHERIN with and without 10% strain. All quantification from three independent replicates. Unpaired t test P values <0.05 (*), <0.01 (**), <0.001(***), n.s.: not significant.
Gene Exp Fgf4 Hs00173564 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf4+gene/pmc06428113-269-53--1?v=Thermo+Fisher
Average 88 stars, based on 1 article reviews
gene exp fgf4 hs00173564 m1 - by Bioz Stars, 2026-07
88/100 stars
  Buy from Supplier

87
Thermo Fisher gene exp fgf4 mm00438916 g1
Effect of addition of excess FGF2 or <t>FGF4</t> to Oct4 -deleted IOD embryos. (A) Confocal images of two untreated IOD embryos (top two panels) and two 4-OHT-treated embryos (bottom two panels) cultured from the 8-cell stage (E2.5) for 48 hours, as indicated in , supplemented with 1 mg/ml FGF4 (or FGF2) from 24-48 hours showing Oct4 (white), Nanog (green), Sox17 (red) and DAPI (blue). (B) Average numbers of cells expressing Sox17, Nanog and total cell number. The number of embryos used for each data point is indicated beneath the x -axis. Error bars represent s.d. (C-E) Phase contrast images of whole blastocyst outgrowths from IOD embryos following 5 days in culture after (C) culture for 24 hours from the 8-cell stage with treatment, (D) 24 hours with 4-OHT, (E) 24 hours with 4-OHT and FGF2. Scale bar: 50 μm.
Gene Exp Fgf4 Mm00438916 G1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 87/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf4+gene/pmc03929414-194-13--1?v=Thermo+Fisher
Average 87 stars, based on 1 article reviews
gene exp fgf4 mm00438916 g1 - by Bioz Stars, 2026-07
87/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp fgf4 mm00438917 m1
Effect of addition of excess FGF2 or <t>FGF4</t> to Oct4 -deleted IOD embryos. (A) Confocal images of two untreated IOD embryos (top two panels) and two 4-OHT-treated embryos (bottom two panels) cultured from the 8-cell stage (E2.5) for 48 hours, as indicated in , supplemented with 1 mg/ml FGF4 (or FGF2) from 24-48 hours showing Oct4 (white), Nanog (green), Sox17 (red) and DAPI (blue). (B) Average numbers of cells expressing Sox17, Nanog and total cell number. The number of embryos used for each data point is indicated beneath the x -axis. Error bars represent s.d. (C-E) Phase contrast images of whole blastocyst outgrowths from IOD embryos following 5 days in culture after (C) culture for 24 hours from the 8-cell stage with treatment, (D) 24 hours with 4-OHT, (E) 24 hours with 4-OHT and FGF2. Scale bar: 50 μm.
Gene Exp Fgf4 Mm00438917 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf4+gene/pmc10292157-406-56-18?v=Thermo+Fisher
Average 86 stars, based on 1 article reviews
gene exp fgf4 mm00438917 m1 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Collateral Therapeutics bfgf gene therapy
Effect of addition of excess FGF2 or <t>FGF4</t> to Oct4 -deleted IOD embryos. (A) Confocal images of two untreated IOD embryos (top two panels) and two 4-OHT-treated embryos (bottom two panels) cultured from the 8-cell stage (E2.5) for 48 hours, as indicated in , supplemented with 1 mg/ml FGF4 (or FGF2) from 24-48 hours showing Oct4 (white), Nanog (green), Sox17 (red) and DAPI (blue). (B) Average numbers of cells expressing Sox17, Nanog and total cell number. The number of embryos used for each data point is indicated beneath the x -axis. Error bars represent s.d. (C-E) Phase contrast images of whole blastocyst outgrowths from IOD embryos following 5 days in culture after (C) culture for 24 hours from the 8-cell stage with treatment, (D) 24 hours with 4-OHT, (E) 24 hours with 4-OHT and FGF2. Scale bar: 50 μm.
Bfgf Gene Therapy, supplied by Collateral Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf4+gene/pm39105478-230-15-0?v=Collateral+Therapeutics
Average 90 stars, based on 1 article reviews
bfgf gene therapy - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Angionetics Inc fgf-4 gene therapy
ATMP candidates in the industrial pipeline in phase III/IV clinical trial.
Fgf 4 Gene Therapy, supplied by Angionetics Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf4+gene/pmc06493298-76-0-7?v=Angionetics+Inc
Average 90 stars, based on 1 article reviews
fgf-4 gene therapy - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

86
Thermo Fisher gene exp fgf4 rn00709728 m1
ATMP candidates in the industrial pipeline in phase III/IV clinical trial.
Gene Exp Fgf4 Rn00709728 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf4+gene/pm18429950-87-16--1?v=Thermo+Fisher
Average 86 stars, based on 1 article reviews
gene exp fgf4 rn00709728 m1 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Berlex Laboratories Inc adenovirus mediated human fgf-4 gene transfer
ATMP candidates in the industrial pipeline in phase III/IV clinical trial.
Adenovirus Mediated Human Fgf 4 Gene Transfer, supplied by Berlex Laboratories Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/fgf4+gene/10__1089_slash_blr__1999__18__45-441-14-33?v=Berlex+Laboratories+Inc
Average 90 stars, based on 1 article reviews
adenovirus mediated human fgf-4 gene transfer - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

N/A
Full length Clone DNA of Human fibroblast growth factor 4
  Buy from Supplier

N/A
Full length Clone DNA of Human fibroblast growth factor 4 with C terminal HA tag
  Buy from Supplier

N/A
FGF4 KN2 0 Human gene knockout kit via CRISPR non homology mediated
  Buy from Supplier

N/A
Full length Clone DNA of Mouse fibroblast growth factor 4
  Buy from Supplier

N/A
Full length Clone DNA of Human fibroblast growth factor 4 with C terminal GFPSpark tag
  Buy from Supplier

Image Search Results


Molecular characterization and identification of 10% strain applied human ESCs for 2 h via qRT-PCR analysis for temporal expression of (A) pluripotency (NANOG, OCT4, SOX2, and KLF4), (B) trophoctoderm markers (CDX2, EOMES, EpCAM, and FGF4), (C) ecto- and endodermal lineage differentiation (WNT3A, SOX17, GATA6, and PAX6), and (D) cytoskeletal, focal adhesion kinase (Ptk2) and PXN (Paxillin), Integrin alpha 6 (ITGA6) and E-CADHERIN with and without 10% strain. All quantification from three independent replicates. Unpaired t test P values <0.05 (*), <0.01 (**), <0.001(***), n.s.: not significant.

Journal: Integrative Biology

Article Title: Rapid translocation of pluripotency-related transcription factors by external uniaxial forces

doi: 10.1093/intbio/zyz003

Figure Lengend Snippet: Molecular characterization and identification of 10% strain applied human ESCs for 2 h via qRT-PCR analysis for temporal expression of (A) pluripotency (NANOG, OCT4, SOX2, and KLF4), (B) trophoctoderm markers (CDX2, EOMES, EpCAM, and FGF4), (C) ecto- and endodermal lineage differentiation (WNT3A, SOX17, GATA6, and PAX6), and (D) cytoskeletal, focal adhesion kinase (Ptk2) and PXN (Paxillin), Integrin alpha 6 (ITGA6) and E-CADHERIN with and without 10% strain. All quantification from three independent replicates. Unpaired t test P values <0.05 (*), <0.01 (**), <0.001(***), n.s.: not significant.

Article Snippet: All primers were purchased from ThermoFisher Life Technologies. table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene symbol Assay ID UniGene ID NANOG Hs02387400_g1 Hs.635882 POU5F1 (OCT 3/4) Hs03005111_g1 (FAM-MGB) Hs.249184 SOX2 Hs01053049 (FAM-MGB) Hs.518438 FAK (PTK2) Hs03657683 Hs.395482 CDX2 Hs01078080_m1 Hs.127383 E-CADHERIN Hs01023894_m1 Hs.461086 PXN Hs01104424_m1 Hs.446336 EOMES Hs00172872_m1 Hs.591663 FGF4 Hs00173564_m1 Hs.1755 EPCAM Hs00901885_m1 Hs.542050 WNT3A Hs00263977_m1 Hs.336930 SOX17 Hs00751752_s1 Hs.98367 GATA6 Hs00232018_m1 Hs.514746 PAX6 Hs00240871_m1 Hs.446336 ITGA6 Hs01041011_m1 Hs.133397 KLF4 Hs00358836_m1 Hs.376206 GAPDH Hs02786624_g1 Hs.544577 Open in a separate window Primer sets used in qRT-PCR

Techniques: Quantitative RT-PCR, Expressing

Primer sets used in qRT-PCR

Journal: Integrative Biology

Article Title: Rapid translocation of pluripotency-related transcription factors by external uniaxial forces

doi: 10.1093/intbio/zyz003

Figure Lengend Snippet: Primer sets used in qRT-PCR

Article Snippet: All primers were purchased from ThermoFisher Life Technologies. table ft1 table-wrap mode="anchored" t5 Table 2. caption a7 Gene symbol Assay ID UniGene ID NANOG Hs02387400_g1 Hs.635882 POU5F1 (OCT 3/4) Hs03005111_g1 (FAM-MGB) Hs.249184 SOX2 Hs01053049 (FAM-MGB) Hs.518438 FAK (PTK2) Hs03657683 Hs.395482 CDX2 Hs01078080_m1 Hs.127383 E-CADHERIN Hs01023894_m1 Hs.461086 PXN Hs01104424_m1 Hs.446336 EOMES Hs00172872_m1 Hs.591663 FGF4 Hs00173564_m1 Hs.1755 EPCAM Hs00901885_m1 Hs.542050 WNT3A Hs00263977_m1 Hs.336930 SOX17 Hs00751752_s1 Hs.98367 GATA6 Hs00232018_m1 Hs.514746 PAX6 Hs00240871_m1 Hs.446336 ITGA6 Hs01041011_m1 Hs.133397 KLF4 Hs00358836_m1 Hs.376206 GAPDH Hs02786624_g1 Hs.544577 Open in a separate window Primer sets used in qRT-PCR

Techniques:

Effect of addition of excess FGF2 or FGF4 to Oct4 -deleted IOD embryos. (A) Confocal images of two untreated IOD embryos (top two panels) and two 4-OHT-treated embryos (bottom two panels) cultured from the 8-cell stage (E2.5) for 48 hours, as indicated in , supplemented with 1 mg/ml FGF4 (or FGF2) from 24-48 hours showing Oct4 (white), Nanog (green), Sox17 (red) and DAPI (blue). (B) Average numbers of cells expressing Sox17, Nanog and total cell number. The number of embryos used for each data point is indicated beneath the x -axis. Error bars represent s.d. (C-E) Phase contrast images of whole blastocyst outgrowths from IOD embryos following 5 days in culture after (C) culture for 24 hours from the 8-cell stage with treatment, (D) 24 hours with 4-OHT, (E) 24 hours with 4-OHT and FGF2. Scale bar: 50 μm.

Journal: Development (Cambridge, England)

Article Title: Oct4 is required for lineage priming in the developing inner cell mass of the mouse blastocyst

doi: 10.1242/dev.096875

Figure Lengend Snippet: Effect of addition of excess FGF2 or FGF4 to Oct4 -deleted IOD embryos. (A) Confocal images of two untreated IOD embryos (top two panels) and two 4-OHT-treated embryos (bottom two panels) cultured from the 8-cell stage (E2.5) for 48 hours, as indicated in , supplemented with 1 mg/ml FGF4 (or FGF2) from 24-48 hours showing Oct4 (white), Nanog (green), Sox17 (red) and DAPI (blue). (B) Average numbers of cells expressing Sox17, Nanog and total cell number. The number of embryos used for each data point is indicated beneath the x -axis. Error bars represent s.d. (C-E) Phase contrast images of whole blastocyst outgrowths from IOD embryos following 5 days in culture after (C) culture for 24 hours from the 8-cell stage with treatment, (D) 24 hours with 4-OHT, (E) 24 hours with 4-OHT and FGF2. Scale bar: 50 μm.

Article Snippet: The following TaqMan probes were used: Pou5f1, Mm03053917_g1; Nanog, Mm02019550_s1; Pdgfrα, Mm00440701_m1; Fgf4, Mm00438916_g1; Fgfr2, Mm01269930_m1.

Techniques: Cell Culture, Expressing

Model of Oct4 functions during preimplantation development. As shown in , levels of Nanog protein are higher when Oct4 is subject to maternal-zygotic deletion, implying that Oct4 plays a role in restricting Nanog to maintain flexibility for formation of PrE. It is known from previous work ( ; ) that Oct4 is required to suppress Cdx2 and trophectoderm differentiation in the mid-late ICM. Single-cell expression analysis suggests that sustained expression of Oct4 beyond the 8-cell stage is required to enable the segregation of molecular programmes for either epiblast or PrE. However, expression of Sox17 can be induced by addition of excess FGF2 or FGF4, and overt differentiation of PrE derivatives is possible in cells from which Oct4 was conditionally deleted from the morula stage following ESC complementation from the 8-cell stage.

Journal: Development (Cambridge, England)

Article Title: Oct4 is required for lineage priming in the developing inner cell mass of the mouse blastocyst

doi: 10.1242/dev.096875

Figure Lengend Snippet: Model of Oct4 functions during preimplantation development. As shown in , levels of Nanog protein are higher when Oct4 is subject to maternal-zygotic deletion, implying that Oct4 plays a role in restricting Nanog to maintain flexibility for formation of PrE. It is known from previous work ( ; ) that Oct4 is required to suppress Cdx2 and trophectoderm differentiation in the mid-late ICM. Single-cell expression analysis suggests that sustained expression of Oct4 beyond the 8-cell stage is required to enable the segregation of molecular programmes for either epiblast or PrE. However, expression of Sox17 can be induced by addition of excess FGF2 or FGF4, and overt differentiation of PrE derivatives is possible in cells from which Oct4 was conditionally deleted from the morula stage following ESC complementation from the 8-cell stage.

Article Snippet: The following TaqMan probes were used: Pou5f1, Mm03053917_g1; Nanog, Mm02019550_s1; Pdgfrα, Mm00440701_m1; Fgf4, Mm00438916_g1; Fgfr2, Mm01269930_m1.

Techniques: Expressing

ATMP candidates in the industrial pipeline in phase III/IV clinical trial.

Journal: Journal of Market Access & Health Policy

Article Title: Technology forecast: advanced therapies in late clinical research, EMA approval or clinical application via hospital exemption

doi: 10.1080/20016689.2019.1600939

Figure Lengend Snippet: ATMP candidates in the industrial pipeline in phase III/IV clinical trial.

Article Snippet: Generx (FGF-4 gene therapy) , NCT02928094 , Angionetics Inc. , Coronary artery disease , Completed.

Techniques: Derivative Assay, Polymer